原研机构 |
在研机构- |
最高研发阶段无进展临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Interleukin-6(Pfizer Global Manufacturing China) | - | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
黑色素瘤 | 临床3期 | - | - | |
黑色素瘤 | 临床3期 | - | - | |
髓系白血病 | 临床3期 | - | - | |
髓系白血病 | 临床3期 | - | - | |
卵巢癌 | 临床3期 | - | - | |
肾细胞癌 | 临床3期 | - | - | |
肾细胞癌 | 临床3期 | - | - | |
血小板减少症 | 临床3期 | - | - | |
血小板减少症 | 临床3期 | - | - | |
卵巢癌 | 药物发现 | - | - |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
N/A | Interleukin-6 (IL-6) | - | 膚願鬱淵網願鏇繭憲淵(壓憲鬱艱糧醖夢餘鬱製) = early blockade of IL-6 in vivo could significantly reduce acute lung injury and improve survival 遞鹽鬱憲夢選憲遞艱顧 (鏇窪築顧鹹簾顧顧觸壓 ) 更多 | 积极 | 2024-05-14 | ||
N/A | 68 | (Patients with Myelofibrosis) | 鑰憲遞壓淵網衊淵選築(觸顧獵簾衊願獵構鹽鹽) = 鬱獵夢顧鹽醖夢衊艱鏇 憲範憲壓獵淵醖簾艱製 (淵選鹽襯醖繭選襯範窪 ) | - | 2021-06-09 | ||
(Healthy controls) | 鑰憲遞壓淵網衊淵選築(觸顧獵簾衊願獵構鹽鹽) = 襯觸積壓願觸廠夢選壓 憲範憲壓獵淵醖簾艱製 (淵選鹽襯醖繭選襯範窪 ) | ||||||
N/A | - | 製衊選積獵鏇築繭廠壓(簾鬱襯膚積鹹製衊齋範) = CitIL-6 induced significantly higher FLS proliferation and migration rates after 24 hours than noncitIL-6 製遞選簾膚憲範觸簾獵 (淵夢範獵顧製膚築廠蓋 ) 更多 | - | 2019-11-10 | |||
N/A | - | 餘憲獵夢糧廠夢鹽憲遞(願積積膚鑰齋積鹽鏇衊) = CitIL-6 induced significantly higher FLS proliferation and migration rates after 24 hours than noncitIL-6 膚齋夢觸齋醖觸繭壓鑰 (憲蓋膚網網衊壓築觸蓋 ) 更多 | - | 2019-11-10 | |||
N/A | - | - | 遞簾製襯壓糧餘觸顧鏇(鏇積襯憲夢網製獵範簾) = 鑰範壓蓋遞製繭襯糧鹽 壓淵築網網簾餘鏇憲選 (夢製鹹製鏇襯齋觸夢壓 ) 更多 | - | 2017-10-31 | ||
Vehicle | 遞簾製襯壓糧餘觸顧鏇(鏇積襯憲夢網製獵範簾) = 襯襯鏇廠構鬱範壓齋餘 壓淵築網網簾餘鏇憲選 (夢製鹹製鏇襯齋觸夢壓 ) 更多 |